Avidity Biosciences, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| FMR LLC | 11/13/2025 | 21.59 M | $940.50 M | 33.36% | 16.65% |
| JANUS HENDERSON GROUP PLC | 11/14/2025 | 14.52 M | $632.81 M | 34.75% | 11.20% |
| VANGUARD GROUP INC | 11/07/2025 | 13.22 M | $575.98 M | 42.94% | 10.20% |
| RTW INVESTMENTS, LP | 11/14/2025 | 11.37 M | $495.51 M | 18.23% | 8.77% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2025 | 10.07 M | $438.54 M | 8.82% | 7.77% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2025 | 9.79 M | $426.44 M | -9.45% | 7.55% |
| BLACKROCK, INC. | 11/12/2025 | 9.20 M | $400.96 M | -1.44% | 7.10% |
| RA CAPITAL MANAGEMENT, L.P. | 11/14/2025 | 8.64 M | $376.49 M | 18.92% | 6.67% |
| AVORO CAPITAL ADVISORS LLC | 11/14/2025 | 7.65 M | $333.09 M | 8.44% | 5.90% |
| STATE STREET CORP | 11/14/2025 | 4.89 M | $213.00 M | 16.35% | 3.77% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 2.86 M | $124.55 M | 0.35% | 2.20% |
| POLAR CAPITAL HOLDINGS PLC | 11/14/2025 | 2.80 M | $121.85 M | 57.97% | 2.16% |
| BELLEVUE GROUP AG | 11/14/2025 | 2.15 M | $93.80 M | 100.00% | 1.66% |
| CASDIN CAPITAL, LLC | 11/14/2025 | 1.78 M | $77.55 M | 0.28% | 1.37% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 1.73 M | $75.48 M | 51.24% | 1.34% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 1.73 M | $75.17 M | -6.21% | 1.33% |
| ORBIMED ADVISORS LLC | 11/14/2025 | 1.64 M | $71.41 M | -9.60% | 1.26% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 11/14/2025 | 1.40 M | $61.08 M | 72.24% | 1.08% |
| PICTET ASSET MANAGEMENT HOLDING SA | 11/18/2025 | 1.34 M | $58.23 M | 38.29% | 1.03% |
| UBS GROUP AG | 11/13/2025 | 1.32 M | $57.33 M | 120.58% | 1.02% |
| SIREN, L.L.C. | 11/13/2025 | 1.29 M | $56.01 M | 15.76% | 0.99% |
| FIERA CAPITAL CORP | 11/07/2025 | 1.20 M | $52.39 M | 53.78% | 0.93% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2025 | 1.20 M | $52.28 M | -21.41% | 0.93% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 1.12 M | $48.96 M | 7.21% | 0.87% |
| NORTHERN TRUST CORP | 11/14/2025 | 975.06 K | $42.48 M | -2.21% | 0.75% |
| ARTISAN PARTNERS LIMITED PARTNERSHIP | 11/12/2025 | 903.29 K | $39.36 M | 2.42% | 0.70% |
| CITADEL ADVISORS LLC | 11/14/2025 | 899.76 K | $39.20 M | 4,042.18% | 0.69% |
| JPMORGAN CHASE & CO | 11/26/2025 | 899.56 K | $39.19 M | 55.02% | 0.69% |
| SOFINNOVA INVESTMENTS, INC. | 11/14/2025 | 875.93 K | $38.16 M | 49.78% | 0.68% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 11/12/2025 | 844.63 K | $36.80 M | 106.01% | 0.65% |
| ECOR1 CAPITAL, LLC | 11/14/2025 | 765.00 K | $33.33 M | 53.00% | 0.59% |
| BIOIMPACT CAPITAL LLC | 11/14/2025 | 760.02 K | $33.11 M | 0.00% | 0.59% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 11/14/2025 | 750.00 K | $32.68 M | 100.00% | 0.58% |
| CLEARBRIDGE INVESTMENTS, LLC | 11/13/2025 | 741.69 K | $32.32 M | 100.00% | 0.57% |
| MORGAN STANLEY | 11/14/2025 | 691.51 K | $30.13 M | 55.09% | 0.53% |
| MARSHALL WACE, LLP | 11/13/2025 | 639.58 K | $27.87 M | 962.03% | 0.49% |
| BAKER BROS. ADVISORS LP | 11/14/2025 | 625.00 K | $27.23 M | 100.00% | 0.48% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 11/14/2025 | 625.00 K | $27.23 M | 0.00% | 0.48% |
| LOGOS GLOBAL MANAGEMENT LP | 11/14/2025 | 600.00 K | $26.14 M | -36.84% | 0.46% |
| ENSIGN PEAK ADVISORS, INC | 11/13/2025 | 580.86 K | $25.31 M | 9.43% | 0.45% |
| CANDRIAM S.C.A. | 11/06/2025 | 487.92 K | $21.26 M | 10.20% | 0.38% |
| TD ASSET MANAGEMENT INC | 11/10/2025 | 457.17 K | $19.92 M | 13.05% | 0.35% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 11/14/2025 | 446.13 K | $19.44 M | 4.08% | 0.34% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 414.20 K | $18.05 M | 463.54% | 0.32% |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 11/13/2025 | 406.03 K | $17.31 M | 18.13% | 0.31% |
| NEW YORK STATE COMMON RETIREMENT FUND | 11/03/2025 | 392.64 K | $17.11 M | 44.21% | 0.30% |
| DIMENSIONAL FUND ADVISORS LP | 11/12/2025 | 385.49 K | $16.79 M | 16.62% | 0.30% |
| BANK OF NEW YORK MELLON CORP | 11/03/2025 | 381.83 K | $16.64 M | -0.35% | 0.29% |
| EVENTIDE ASSET MANAGEMENT, LLC | 11/14/2025 | 375.99 K | $16.38 M | 0.02% | 0.29% |
| BARCLAYS PLC | 11/12/2025 | 352.29 K | $15.35 M | -5.24% | 0.27% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Avidity Biosciences, Inc. institutional Ownership - FAQ's
During the previous two years, 311 institutional investors and hedge funds held shares of Avidity Biosciences, Inc.. The most heavily invested institutionals were:
FMR LLC: 21.59 M
JANUS HENDERSON GROUP PLC: 14.52 M
VANGUARD GROUP INC: 13.22 M
RTW INVESTMENTS, LP: 11.37 M
WELLINGTON MANAGEMENT GROUP LLP: 10.07 M
PRICE T ROWE ASSOCIATES INC /MD/: 9.79 M
124.17% of Avidity Biosciences, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 173.48 M shares in the last 24 months. This purchase volume represents approximately $8.15 B in transactions.